Unknown

Dataset Information

0

New Discovery of Curcumin Combination Therapy and Action Mechanism.

ABSTRACT:

SUBMITTER: Dai C 

PROVIDER: S-EPMC7085841 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

New Discovery of Curcumin Combination Therapy and Action Mechanism.

Dai Chongshan C   Zhang Xiuying X   Zhang Keyu K  

Evidence-based complementary and alternative medicine : eCAM 20200310

Similar Datasets

Unknown Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action.
| S-EPMC3480206 | biostudies-literature
Unknown The discovery and mechanism of action of letrozole.
| S-EPMC2001216 | biostudies-literature
Unknown New Hypoglycemic Drugs: Combination Drugs and Targets Discovery.
| S-EPMC9295075 | biostudies-literature
Unknown Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action.
| S-EPMC10103628 | biostudies-literature
Unknown Discovery of a new function of curcumin which enhances its anticancer therapeutic potency.
| S-EPMC4967984 | biostudies-literature
Unknown Independent Drug Action in Combination Therapy: Implications for Precision Oncology.
| S-EPMC8904281 | biostudies-literature
Unknown Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery.
| S-EPMC5075082 | biostudies-literature
Unknown Highlights in Resistance Mechanism Pathways for Combination Therapy.
| S-EPMC6770082 | biostudies-literature
Unknown Discovery of first-in-class nanomolar inhibitors of heptosyltransferase I reveals a new aminoglycoside target and potential alternative mechanism of action.
| S-EPMC9068772 | biostudies-literature
Unknown Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.
| S-EPMC7336273 | biostudies-literature